Lupin Limited has informed the Exchange regarding a press release dated July 11, 2023, titled "Lupin Receives EIR from U.S. FDA for its Pithampur Unit-2 Manufacturing Facility.".
Lupin Limited has informed the Exchange regarding a press release dated July 11, 2023, titled "Lupin Receives EIR from U.S. FDA for its Pithampur Unit-2 Manufacturing Facility.".